Jim Cramer made the following calls on September 27th, 2013. What do you think about his picks?
Insys Therapeutics Inc. (NASDAQ:INSY): Jim Cramer ranked this stock a Buy. The stock’s 52-week high is $37.94, and its 52-week low is $6.55. Cramer said that the stock is reasonably valued even though it has risen by over 300 percent this year, making Insys Therapeutics a reasonable call for someone looking to invest in a company that hasn’t been around for all that long. The company has posted especially strong gains in the past two months, a trend Cramer expects could continue into October as the stock builds momentum.